ID

16754

Description

Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00079872

Lien

https://clinicaltrials.gov/show/NCT00079872

Mots-clés

Versions (1)
  1. 04/08/2016 04/08/2016 -
Téléchargé le

4 août 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Colorectal Cancer NCT00079872

Anglais

Eligibility Colorectal Cancer NCT00079872

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient must have:
Description

ID.1

Type de données

boolean

histologic or cytologic diagnosis of adenocarcinoma of the colon or rectum.
Description

Adenocarcinoma of colon | Adenocarcinoma of rectum

Type de données

boolean

Alias
UMLS CUI [1]
C0338106
UMLS CUI [2]
C0149978
performance status of 0 to 2 on the ecog performance status scale.
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
standard postoperative adjuvant radiation therapy for rectal cancer is allowed.
Description

adjuvant postoperative radiation therapy Rectal Carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C3162256
UMLS CUI [1,2]
C0007113
locally advanced or metastatic disease.
Description

Locally Advanced Malignant Neoplasm | Neoplasm Metastasis

Type de données

boolean

Alias
UMLS CUI [1]
C0677984
UMLS CUI [2]
C0027627
must be 18 years of age.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient must not have:
Description

ID.7

Type de données

boolean

received prior chemotherapy for advanced disease. prior adjuvant therapy, including 5-fu, is allowed if it has been more than 12 months since the last treatment.
Description

Prior Chemotherapy advanced disease | Prior Adjuvant Therapy | Fluorouracil

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0679246
UMLS CUI [2]
C1514456
UMLS CUI [3]
C0016360
received prior treatment with irinotecan in the adjuvant setting.
Description

irinotecan | Prior Adjuvant Therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0123931
UMLS CUI [2]
C1514456
are unable to take vitamin b12 or folic acid.
Description

Able to take medication Vitamin B 12 | Able to take medication Folic Acid

Type de données

boolean

Alias
UMLS CUI [1,1]
C4075001
UMLS CUI [1,2]
C0042845
UMLS CUI [2,1]
C4075001
UMLS CUI [2,2]
C0016410
are unable to interrupt aspirin, other nonsteroidal anti-inflammatory drugs, or cox-2 inhibitors for a 5-day period.
Description

Aspirin Interrupt Unable | Non-Steroidal Anti-Inflammatory Agents Interrupt Unable | Cyclooxygenase 2 Inhibitors Interrupt Unable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0443239
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0003211
UMLS CUI [2,2]
C0443239
UMLS CUI [2,3]
C1299582
UMLS CUI [3,1]
C1257954
UMLS CUI [3,2]
C0443239
UMLS CUI [3,3]
C1299582
have a second primary malignancy except carcinoma in situ of the cervix or nonmelanomatous skin cancer, unless that prior malignancy was diagnosed and definitively treated at least 5 years previously with no subsequent evidence of recurrence.
Description

Second Primary Cancer | Carcinoma in situ of uterine cervix | Skin carcinoma | Malignant Neoplasm Previous Treated Definitive | Recurrence Evidence

Type de données

boolean

Alias
UMLS CUI [1]
C0751623
UMLS CUI [2]
C0851140
UMLS CUI [3]
C0699893
UMLS CUI [4,1]
C0006826
UMLS CUI [4,2]
C0205156
UMLS CUI [4,3]
C1522326
UMLS CUI [4,4]
C0443196
UMLS CUI [5,1]
C0034897
UMLS CUI [5,2]
C3887511
Retour au début de la page

Similar models

Eligibility Colorectal Cancer NCT00079872

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
the patient must have:
boolean
Adenocarcinoma of colon | Adenocarcinoma of rectum
Item
histologic or cytologic diagnosis of adenocarcinoma of the colon or rectum.
boolean
C0338106 (UMLS CUI [1])
C0149978 (UMLS CUI [2])
ECOG performance status
Item
performance status of 0 to 2 on the ecog performance status scale.
boolean
C1520224 (UMLS CUI [1])
adjuvant postoperative radiation therapy Rectal Carcinoma
Item
standard postoperative adjuvant radiation therapy for rectal cancer is allowed.
boolean
C3162256 (UMLS CUI [1,1])
C0007113 (UMLS CUI [1,2])
Locally Advanced Malignant Neoplasm | Neoplasm Metastasis
Item
locally advanced or metastatic disease.
boolean
C0677984 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
Age
Item
must be 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.7
Item
the patient must not have:
boolean
Prior Chemotherapy advanced disease | Prior Adjuvant Therapy | Fluorouracil
Item
received prior chemotherapy for advanced disease. prior adjuvant therapy, including 5-fu, is allowed if it has been more than 12 months since the last treatment.
boolean
C1514457 (UMLS CUI [1,1])
C0679246 (UMLS CUI [1,2])
C1514456 (UMLS CUI [2])
C0016360 (UMLS CUI [3])
irinotecan | Prior Adjuvant Therapy
Item
received prior treatment with irinotecan in the adjuvant setting.
boolean
C0123931 (UMLS CUI [1])
C1514456 (UMLS CUI [2])
Able to take medication Vitamin B 12 | Able to take medication Folic Acid
Item
are unable to take vitamin b12 or folic acid.
boolean
C4075001 (UMLS CUI [1,1])
C0042845 (UMLS CUI [1,2])
C4075001 (UMLS CUI [2,1])
C0016410 (UMLS CUI [2,2])
Aspirin Interrupt Unable | Non-Steroidal Anti-Inflammatory Agents Interrupt Unable | Cyclooxygenase 2 Inhibitors Interrupt Unable
Item
are unable to interrupt aspirin, other nonsteroidal anti-inflammatory drugs, or cox-2 inhibitors for a 5-day period.
boolean
C0004057 (UMLS CUI [1,1])
C0443239 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0003211 (UMLS CUI [2,1])
C0443239 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C1257954 (UMLS CUI [3,1])
C0443239 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
Second Primary Cancer | Carcinoma in situ of uterine cervix | Skin carcinoma | Malignant Neoplasm Previous Treated Definitive | Recurrence Evidence
Item
have a second primary malignancy except carcinoma in situ of the cervix or nonmelanomatous skin cancer, unless that prior malignancy was diagnosed and definitively treated at least 5 years previously with no subsequent evidence of recurrence.
boolean
C0751623 (UMLS CUI [1])
C0851140 (UMLS CUI [2])
C0699893 (UMLS CUI [3])
C0006826 (UMLS CUI [4,1])
C0205156 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C0443196 (UMLS CUI [4,4])
C0034897 (UMLS CUI [5,1])
C3887511 (UMLS CUI [5,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial